to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
At-the-market offerings are used for investing in other industries, but they are just starting to pick up in life science investing. Read more on what the healthcare business should know about ATM offerings.
The process venture capitalists go through to decide which entrepreneurial ventures to fund can be something of a mystery. Chicago-based VC, Matt McCall, provides a description of the qualities he looks for in the CEOs he backs, including resourcefulness, relentless determination, and creative thought.
Matt McCall posts about Sequoia Capital and how this VC firm describes the elements of sustainability they seek within the ventures they fund, such as clarity of purpose, large markets with rich customers, and focus.
For years, Dave Felker created equipment for one of the world's leading golf companies, Calloway Golf. There he designed golf balls and clubs for the game's best golfers. Then, Dave left Calloway. Throwing the USGA rules out the window and using the laws of physics instead, Dave created the Polara golf ball, which would help correct an average golfer's hook or slice.
Buyers and sellers of companies have different reasons for getting together.
It’s no secret that the economy is in sickbay. But healthcare entrepreneurs looking for a big transfusion of cash shouldn’t look to an initial public offering.
Healthcare investing by venture capitalists dropped to its lowest level in five quarters, but the decrease follows a five-quarter high. Read more for details.
Hatteras Venture Partners, a venture capital firm, will invest $20 million to $30 million in helping companies through first-in-man and preclinical studies. The firm expects to invest in 10 to 15 companies in the healthcare business.
The venture capital climate improved in RTP in the first quarter, but biotech companies are still competing for dollars. Several RTP companies saw venture capital investment for development of pharmaceutical products and medical technologies. Read more to learn about the venture capital climate.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.